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standard molecular biology techniques. The method
includes a procedure for screening large numbers of
mutageniZed plant cell cultures for activation of a relevant
gene on the basis of the desired protein product on the basis

of radioligand binding displacement assay.
12 Claims, 11 Drawing Sheets
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METHODS TO IDENTIFY PLANT
METABOLITES

statements as to the date or representation as to the contents

of these documents is based on subjective characteriZation
of information available to the applicant and does not

CROSS REFERENCE TO RELATED
APPLICATION

constitute any admission as to the accuracy of the dates or
contents of these documents.

This application claims bene?t of priority from US.
Provisional Application Ser. No. 60,267,438, ?led Feb. 9,

SUMMARY OF THE INVENTION

2001.
10

BACKGROUND OF THE INVENTION

The present invention provides a method for identifying
plant genetic material Whose actions cause increased pro
duction of a metabolite or metabolites of interest in plant

cells, said method comprising causing random integration
Plants are sources of drugs and other useful materials.

into the plant genome in plant protoplasts of at least one

These materials are the products of plant metabolism, Which
is the total collection of biochemical pathWays Within a

enhancer-containing T-DNA genetic element harboring
15

plant. Genes encode the enZymes that function in plant
metabolic pathWays and regulatory genes, in turn, control

sequences to enable bacterial replication and selection;
groWing said protoplasts to the stage of callus cultures;
sampling said callus cultures in such a manner as to retain

the activity of metabolic pathWays by directing the expres

viability of said clonal cultures; analyZing said samples to

sion of entire sets of enZyme-encoding genes speci?c to a

identify the callus cultures producing metabolite or metabo

given pathWay. It folloWs that methods to identify any genes
that govern the production of such plant metabolites are
critical to enable the manipulation of pathWays for elevating

lites of interest; and isolating and identifying the plant
genetic material, the action of Which has been stimulated by
the enhancer-containing T-DNA genetic element in the
sampled, identi?ed callus cultures.
Preferred is a method Wherein the plant genetic material,

product yield and for increasing the diversity of these
substances. The present invention provides methods to iden
tify, in a relatively ef?cient and reliable manner, plant

25

genetic material required for production of metabolites
Which Would ordinarily be dif?cult to identify. The invention
is the realiZation of the successful merging of tWo distinct

the plant genetic material, Which is identi?ed, is a regulatory

methodologies: activation-tagging mutagenesis and high

gene. Also preferred is a method Wherein the analysis of
callus cultures detects the production of metabolites of

throughput screening. The present unique combination of
these methodologies results in the ability to assign metabolic
functionality to plant genes involved in the production of

interest having pharmacological properties. Most preferred
is a method Wherein said metabolites are detected via at least

biologically active molecules and to create a means of

compound discovery based on the genetic capabilities of a
plant or group of plants.

Which is identi?ed, is a plant gene Whose action causes a
plant cell to produce an increased amount of a metabolite or
metabolites of interest. More preferred is a method Wherein

35

This invention is therefore based on the folloWing tech

one radioligand displacement assay.
Methods of the present invention, Which comprises the
further step of propagating at least one callus, culture

sample in a miniaturiZed high throughput pharmacological

producing said metabolite or metabolites. Most preferred are
methods, Which involve a tobacco plant.
Most preferred are methods Wherein said enhancer
sequence is a plant viral enhancer sequence.
Most preferred are methods Wherein said enhancer
sequence is delivered to the plant via Agrobacterium tume

screen.

faciens.

nical developments: 1) methodology Which enables propa
gation and maintenance of mutageniZed “microcallus” mate
rial in a “library” format in such a Way as to permit large

scale screening; 2) procedures to nondestructively sample

40

the microcallus; 3) methodology to screen the microcallus

Preferred are methods Wherein said radioligand is a

Therefore, the invention is in the ?eld of plant molecular

biology, in particular, genetic methods for production and

45

antagonist. Most preferred is the radioligand [3H]-epibati

identi?cation of useful compounds.
Identi?cation of plant genes via activation mutagenesis

dine or [3H]-methyllycaconitine.
The present invention provides a method for identifying
plant genetic material Whose actions cause increased pro

has been used With success previous to the present invention.

This technique

involves incorporation of enhancer

sequences from a plant viral promoter at random places into
the plant genome viaAgrobacterium mediated T-DNA trans

fer. When applied to single plant cells in culture, the
resulting mutants are identi?ed by positive selection, and the
gene(s) in the vicinity of the T-DNA insert is cloned.
HoWever, elucidation of the effects of mutations in regula

nicotinic acetylcholine agonist or a nicotinic acetylcholine

duction of a metabolite or metabolites of interest in plant

cells, said method comprising co-cultivating plant proto
plasts With Agrobacterium cells harboring an activation

tagging vector; embedding the plant protoplasts in agarose;
55

transferring the embedded protoplasts to a larger surface
area to alloW further groWth; eXcising individual, clonal calli

tory regions, or doWnstream effects from a mutageniZed

resulting from said groWth; partially macerating individual

gene, are very difficult in cases Where no positive selection

samples of tissue from said calli in multi-Welled microtiter
plates to establish a sample clonal library; removing super
natant liquid fractions from said macerated samples; sub

schemes can be employed. Even With classical activation

mutagenesis methods, Walden et al. conclude “this process
is involved, labor-intensive and can only be effectively
carried out With relatively limited numbers of segregating
individuals.” Walden et al., Methods in Cell Biology,

jecting said supernatant fractions to radioligand displace
ment assays to determine if metabolites in the liquid

supernatant displace the radioligand; adding groWth medium

49:455—469 (1995).
High-throughput screening has also been utiliZed in the

pharmaceutical ?eld.
Citation of the above document is not intended as an

admission that any of the foregoing is pertinent prior art. All

65

to remaining tissues in the microtiter plate; and isolating and
identifying the plant genetic material, the action of Which
has been stimulated by the action of the activation-tagging
vector, from the callus cultures Which generated ligand

displacement in the radioligand displacement assay.

US 6,989,236 B1
3
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The present invention provides methods for detecting a
metabolite in a plant comprising: causing integration of at
least one enhancer-containing T-DNA in a plant protoplast;
groWing said protoplast to the stage of callus culture;

isolated protoplasts from tobacco leaves tWo days after
isolation. At seven days the protoplasts are co-cultivated

With Agrobacterium tumefacians (GV3101) to conduct
transformation resulting in the insertion of the activation

sampling said callus in such a manner so as to retain viability

tagging T-DNA. FIG. 2B shoWs a photograph of a cluster of

of said callus culture; and detecting a metabolite of interest.
Those methods Wherein said metabolite is detected via at
least one radioligand displacement assay are preferred. More
preferred are methods as described Which further comprise
the step of continuous propagation of at least one stably
transformed culture.
In the present invention, methods Wherein the plant is a
tobacco plant are preferred. Those methods Wherein said

clonal cells after several steps of incubation, Washing,
antibiotic selection and embedding of the multiplied proto
plasts. The clusters of clonal cells become macroscopic
10

surface-embedded calli after propagation for approximately
?ve Weeks (compare to microcalli in FIG. 2). This is an

enhancer sequence is a plant viral enhancer sequence are

also preferred. Most preferred are those methods, Which

(referred to as “microcalli”) as shoWn in the dish in the right
of the ?gure. Diameter of the petri dish shoWn is 150 mm.
FIGS. 3A—B. FIG. 3A shoWs a photograph of a plate of

15

utiliZe a viral enchancer sequence, delivered via Agrobac

example of the type of density used of mutageniZed material
used for sampling to conduct the pharmacological assay.

terium tumefaciens.

FIG. 3B shoWs a photograph of a standard 48-well plate

When the detection means is a radioligand displacement
assay, methods Wherein said radioligand is a nicotinic ace
tylcholine agonist or a nicotinic acetylcholine antagonist are

shoWing regroWth of the mutageniZed callus tissue after
sampling and extract preparation Which took place in the
20

preferred. In particular, those methods Wherein said radio
ligand is [3H]-epibatidine are more preferred.

FIG. 4 shoWs a photograph of an “activation-tagging

mutagenesis” (ATM) library that harbors over 1300 indi

Also provided are methods for detecting a metabolite in a

vidual mutant clones. This illustrates the Workability of

plant comprising: co-cultivating protoplasts With Agrobac
terial cells harboring an activation tagging vector; embed
ding the protoplasts in agarose; transferring protoplasts to a
larger surface area to alloW further groWth; excising indi

25

FIGS. 5A—B. FIG. 5A shoWs a photograph of an indi

in a multi-Welled microtitre plate; establishing a viable
30

is expected to have the same displacement activity as the
“parental” tissue. FIG. 5B shoWs that such pieces are also

metabolite displaces the radioligand.

used for plant regeneration from the calli (right half).
35

or more of those compounds or at least one compound. As

such, the terms “a” (or an”), “one or more” and “at least one”
can be used interchangeably herein. It is also to be noted that
the terms “comprising”, “including”, and “having” can be

separate callus tissue. This is used for veri?cation of the

pharmacological phenotype, as each “daughter” individual

medium to tissues remaining in the microtitre plate; and
conducting radioligand displacement assay to determine if a
For the purposes of the present invention, the term “a” or
“an” entity refers to one or more of that entity; for example,
“a metabolite” or “a radioligand” or “an assay” refers to one

establishing a viable “master” library developed using the
methods described herein.

vidual screen-positive callus clone that had been physically
divided and propagated as approximately 20 clonal pieces of

vidual calli tissue; partially macerating individual calli tissue

callus library; removing liquid supernatant; adding groWth

same Wells approximately three Weeks previously.

FIG. 6 shoWs a photograph of plants groWing on synthetic
media in Magenta boxes that had been regenerated from
calli scored as positive in the screen.

FIG. 7 shoWs a graph of displacement data of a population
40

of mutant (“ATM”) and Wild type (“no ATM”) using 3H-epi
batidine as the ligand in the pharmacological screen. Non

used interchangeably. Furthermore, a compound “selected
from the group consisting of” refers to one or more of the

mutated samples shoW average displacement of approxi

compounds in the list that folloWs, including mixtures (i.e.

mately 3% Whereas the ATM population indicates tWo
individuals With greater than 30 and 70% displacement
activity, respectively. Note the log scale on the X-axis. These

combinations) of tWo or more of the compounds. According
to the present invention, an isolated or biologically pure,
protein or nucleic acid molecule is a compound that has been
removed from its natural milieu. As such, “isolated” and
“biologically pure” do not necessarily re?ect the extent to
Which the compound has been puri?ed. An isolated com
pound of the present invention can be obtained from its
natural source, can be produced using molecular biology
techniques or can be produced by chemical synthesis.
These and other objects of the invention Will be more fully

45

data are typical for many thousands of assays run to date.
FIG. 8 shoWs a summary of activities of positive mutant
50

activity 10,000 times higher than that found in Wild-type
calli. This line is no. 7309. The line With the loWest activity

understood from the folloWing description of the invention,
the referenced draWings attached hereto and the claims

55

FIGS. 9A—D. FIGS. 9A and 9B shoW initial activity
characteriZation by displacement activity of line no. 1402
callus (See discussion text). The pure anabasine alkaoid and

BRIEF DESCRIPTION OF THE DRAWINGS
60

a bright ?eld microscope (40>< magni?cation) of freshly

pure nicotine alkaloid are used here to standardiZe the

system. FIGS. 9C and 9D shoW characteriZation of crude

from the detailed description given herein beloW, and the
accompanying draWing, Which is given by Way of illustra
tion only, and thus is not limitative of the present invention.
FIG. 1 shoWs a protoplast isolation and transformation
?owchart.
FIGS. 2A—B. FIG. 2A shoWs a photograph taken through

(and regenerated and analyZed at the Whole plant level) is
no. 1402.

appended hereto.

The present invention Will become more fully understood

lines and Wild-type controls expressed in terms of “nicotine
displacement activity” or approximately equivalent to a
given concentration of nicotine in the displacement assay.
Note log scale on the Y-axis. The upper clone represents

callus extracts performed in the same Way as that in A. This

65

difference in the shape of the pro?les indicates that the
activity in the 1402 extract is distinct from Wildtype and is
most likely a compound other than nicotine.
FIG. 10 shoWs a summary of the molecular characteriZa
tion of cell line 1402.

US 6,989,236 B1
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DETAILED DESCRIPTION OF THE
INVENTION

in the event that the metabolite of interest is present. Those
methods Wherein said metabolite is detected via at least one

radioligand displacement assay are preferred. More pre
The present invention provides a method for identifying
plant genetic material Whose actions cause increased pro

ferred are methods as described Which further comprise the

step of propagating at least one daughter culture.
In the present invention, methods Wherein the plant is a
tobacco plant are preferred. Those methods Wherein said

duction of a metabolite or metabolites of interest in plant

cells, said method comprising causing random or directed
integration into the plant genome in plant protoplasts of at
least one enhancer-containing T-DNA genetic element har
boring sequences to enable bacterial replication and selec
tion; groWing said protoplasts to the stage of callus cultures;

enhancer sequence is a plant viral enhancer sequence are

also preferred. Most preferred are those methods, Which
10

rium tumefaciens.
When the detection means is a radioligand displacement
assay, methods Wherein said radioligand is a nicotinic ace

sampling said callus cultures in such a manner as to retain

viability of said clonal cultures; analyZing said samples to
identify the callus cultures producing metabolite or metabo

lites of interest; and isolating and identifying the plant
genetic material, the action of Which has been stimulated by
the enhancer-containing T-DNA genetic element in the
sampled, identi?ed callus cultures.

utiliZe a viral enhancer sequence, delivered via Agrobacte

15

tylcholine agonist or a nicotinic acetylcholine antagonist are
preferred. In particular, those methods Wherein said radio
ligand is [3H]-epibatidine are more preferred.
Also provided are methods for detecting a metabolite in a

plant comprising: co-cultivation of protoplasts With Agro

Preferred is a method Wherein the plant genetic material,

bacterial cells harboring an activation-tagging vector;

Which is identi?ed, is a plant gene Whose action causes a
plant cell to produce an increased amount of a metabolite or
metabolites of interest. More preferred is a method Wherein

plasts to a larger surface area to alloW further groWth;

the plant genetic material, Which is identi?ed, is a regulatory

vidual calli tissue in multi-Welled microtitre plate; removing

gene. Also preferred is a method Wherein the analysis of
callus cultures detects the production of metabolites of

embedding the protoplasts in agarose; transferring proto

excising individual calli tissue; partially macerating indi

liquid supernatant; conducting radioligand displacement
25

assay to determine if a metabolite displaces the radioligand;

interest having pharmacological properties. Most preferred

and adding groWth medium to tissues remaining in the

is a method Wherein said metabolites are detected via at least

microtitre plate.

one radioligand displacement assay.
Methods of the present invention may also comprise the

bardment and polyethylene glycol-mediated DNA uptake.

further step of propagating at least one callus culture pro
ducing said metabolite or metabolites. Most preferred are

Plant cells may also be transformed With other sequences
With the ability to cause the activation of genes such as

methods, Which involve a tobacco plant and wherein said

enhancer sequences from different promoters and sequences
encoding transcription factors that can function to activate
gene expression or from the introduction of populations of
genes in order to determine their impact on metabolite

enhancer sequence is a plant viral enhancer sequence.
Most preferred are methods Wherein said enhancer
sequence is delivered to the plant via Agrobacterium tume

Other methods of transformation include: biolistic bom

35

production.

faciens.

The supernatant may be assayed for products of second
ary metabolism With radiolabelled ligand binding assays.
Preferred ligands are acetylcholine agonists and antagonists.

Preferred are methods Wherein said radioligand is a

nicotinic acetylcholine agonist or a nicotinic acetylcholine

antagonist. Most preferred is the radioligand [3H]-epibati
dine or [3H]-methyllycaconitine.
In a preferred embodiment, the present invention provides
a method for identifying plant genetic material Whose

40

actions cause increased production of a metabolite or

metabolites of interest in plant cells, said method comprising

co-cultivating plant protoplasts With Agrobacterium cells

45

harboring an activation-tagging vector; embedding the plant
protoplasts in agarose; transferring the embedded proto

More preferred are 3H-methyllycaconitine, 3H-spermidine.
Most preferred is 3H-epibatidine.
Preferred enhancer sequences include tissue-speci?c pro
moter enhancers and temporal-speci?c promoter enhancers.
Most preferred is a constitutive plant viral promoter active
in plant cells and undifferentiated callus tissue.
Enhancer sequences may be contained Within vectors

enabling the transfer of said sequences into the plant

plasts to a larger surface area to alloW further groWth;

excising individual, clonal calli resulting from said groWth;
partially macerating individual samples of tissue from said

genome.
The term “antagonist” is intended to refer to that Which is
understood in the art. In general, the term refers to a

calli in multi-Welled microtiter plates to establish a sample

substance that interferes With receptor function. Antagonists

clonal library; removing supernatant liquid fractions from
said macerated samples; subjecting said supernatant frac

petitive antagonist (or competitive blocker) competes With

are of tWo types: competitive and non-competitive. A com

the naturally occurring ligand for the same binding site. In

tions to radioligand displacement assays to determine if

metabolites in the liquid supernatant displace the radioli
gand; adding groWth medium to remaining tissues in the

55

the case of acetylcholine, an example of such an antagonist

is bungarotoxin. A non-competitive antagonist or blocker
inactivates the functioning of the receptor by binding to a
site other than the acetylcholine-binding site.
Speci?cally, the radiolabeled ligand may bind nicotinic

microtiter plate; and isolating and identifying the plant
genetic material, the action of Which has been stimulated by
the action of the activation-tagging vector, from the callus

ligand displacement assay.

acetylcholine receptors. The preferred radiolabeled ligand is
[3H]-epibatidine, a nicotinic cholinergic receptor agonist.

The present invention provides methods for detecting a
metabolite in a plant comprising: causing integration of at

Cholinergic receptors play an important role in the func
tioning of muscles, organs and generally in the central

cultures Which generated ligand displacement in the radio

least one enhancer-containing T-DNA in a plant protoplast;

groWing said protoplast to the stage of callus culture;
sampling said callus in such a manner so as to retain viability

of said callus culture; and detecting a metabolite of interest

nervous system. There are also complex interactions
65

betWeen cholinergic receptors and the function of receptors
of other neurotransmitters such as dopamine, serotonin and
catecholamines.

US 6,989,236 B1
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Acetylcholine (ACh) serves as the neurotransmitter at all

CoCl2-6H2O, 0.025 g. The vitamin stock solution Was made

autonomic ganglia, at the postganglionic parasympathetic

by dissolving the folloWing in 200 ml H2O: glycine, 400 mg;

nerve endings, and at the postganglionic sympathetic nerve

nicotinic acid, 400 mg; pyridoxin-HCl, 400 mg; thiamin

endings innervating the eccrine sWeat glands. Different

HCl, 20 mg. 5.0 ml of an Fe-EDTA solution Was added from

receptors for ACh exist on the postganglionic neurons Within

a stock, prepared by dissolving 5.57 g FeSO4~7H2O and 7.45

the autonomic ganglia and at the postjunctional autonomic
effector sites. Those Within the autonomic ganglia and
adrenal medulla are stimulated predominantly by nicotine

g NaZEDTA. To prepare K3 containing 0.4 M sucrose,
136.92 g sucrose Was added. 0.1 M sucrose K3 media
contains 34.23 g sucrose.

Protoplast Isolation: Leaves Were digested overnight (no

and are knoWn as nicotinic receptors. Those on autonomic

effector cells are stimulated primarily by the alkaloid mus

10

carine and are knoWn as muscarinic receptors.

more than 19 h) by incubation at 26° C. in the dark. The
folloWing day, 250 ml beakers Were mixed for 10 min on an
orbital shaker (approximately 40 rpm), and the solution Was

The nicotinic receptors of autonomic ganglia and skeletal
muscle are not homogenous because they can be blocked by

passed through a 105 pm mesh sieve by pouring through a

different antagonists. For example, d-tubocurarine effec
tively blocks nicotinic response in skeletal muscle, Whereas

sterile plastic centrifuge tubes, Which Were then centrifuged

?ltration apparatus. This Was divided into 17><100 mm

hexamethonium and mecamylamine are more effective in

at 2000 rpm in a sWinging bucket rotor for 6 minutes at room

blocking nicotinic responses in autonomic ganglia. The

temperature. FolloWing the centrifugation, protoplasts,

nicotinic cholinergic receptors are named the NM and NN

Which ?oat at the top of the media in the centrifuge tube,
Were removed from the pelleted debris by aspirating the
loWer contents of the tube. Protoplasts Were Washed by
addition of 0.4 M K3 media and recentrifuged. The proto

receptors, respectively.
Acetylcholine receptors at any or all of the above men

20

tioned locations may be assayed by radiolabeled ligand
binding assays in the present invention.

plasts from these Were pooled into one or tWo single screW

cap sterile tubes. After adjusting protoplast cell density, cells
EXAMPLES

Were further incubated as 10 ml cultures in standard (60 mm)
25

The folloWing examples illustrate the present invention

petri dishes. Dishes Were Wrapped With para?lm for incu
bation at 26° C. in the dark for tWo days.

Without, hoWever, limiting it. It is to be noted that the
Examples include a number of molecular biology, microbi
ology and biochemistry techniques considered to be knoWn
to those skilled in the art. Disclosure of such techniques can

Example 2
30

Activation-Tagging Mutagenesis: Protoplast
Transformation

be found, for example, in Sambrook et al., ibid., and related
references.

Materials: Agrobacterium tumefaciens strain GV3101, is
Example 1

described
35

Leaf Protoplast Preparation

in

KoncZ

and

Schell,

Mol

Gen

Genet

204:383—396. 1986, Which is incorporated herein by refer
ence in its entirety. The plasmid pPCVICEn4HPT contain
ing the T-DNA tag Was used. It Was made as described in

GroWing Conditions: Tobacco plants (Nicotiana tabacum
SR1) Were groWn in sterile culture on MS media (One liter
contains: 4.3 g MS basal salt mixture (Sigma), 0.5 g MES

FritZe and Walden, Methods in Molecular Biology
44:281—294. 1995 and in Walden, FritZe and Harling, Meth
40

(2-[N-Morpholino]ethanesulfonic acid) (Sigma) for buffer

ods in Cell Biology 49:455—469. 1995, Which references are

incorporated by reference herein in their entirety.
pPCVICEn4HPT is derived from the pPCV vector (KoncZ
and Schell, Mol Gen. Genet 213:285—290, 1986.) in Which

ing, 10 g sucrose. The pH Was adjusted to 5.8 With KOH.

Media Was solidi?ed by adding Phytagel (Sigma) to 0.2%.
SteriliZation Was by autoclaving in Magenta boxes. Magenta

the T-DNA contains four tandemly repeated enhancer ele

boxes contained lids With a vent provided by a 2 cm 45 ments derived from the 35S RNA promoter of the Cauli
diameter hole covered With a single 0.45 pm pore siZe ?lter
?ower mosaic virus, a hygromycin resistance marker for

disc (Type HA, Millipore) and tWo pieces of “Micropore”

protoplast and plant selection and an E. coli plasmid

surgical tape (3 M). Plants groWn for four to ?ve Weeks at

sequence that contains an E. coli origin of replication and an

24° C. under approximately 110 pmol m_2s_1 light intensity
Were used as a source of leaf material.

ampicillin resistance gene.
50

Leaf Preparation Procedure: Under sterile conditions, leaf

faciens harboring the T-DNA tagging element (strain
GV3101, plasmid pPCVICEn4HPT). Freshly groWn bacte

tissue Was removed from the plants and cut into approxi
mately 1 cm2 pieces using a sharp scalpel or raZor blade.
Approximately 5 g of leaf material Was added to 20 ml

?lter-steriliZed enZyme solution (1.5% cellulase, 0.5% pec
tinase, (Sigma)) in K3 plant culture media. K3 media

55

Co-cultivation Was conducted at 26° C. in the dark for 48 hr.

NaHZPO4 (3 g/200 ml); CaCl2 (18 g/200 ml); (NH4)2SO4
(2.7 g/200 ml); MgSO4 (5 g/200 ml); KNO3, (5 g/200 ml);

rotor at room temperature. W5 media contained NaCl, 9.0
60

liter of a micronutrients solution and 1.0 ml per liter of a

vitamin solution. The micronutrient solution Was prepared

g; MnSO4~4H2O, 22.3 g; ZnSO4~7H2O, 10.6 g; KI, 0.88 g;
NaMoO4~2H2O, 0.25 g; CuSO4~5H2O, 0.025 g; and

g/liter; CaCl2~2H2O, 18.38 g/liter; KCl, 0.373 g/liter; and
glucose, 0.90 g/liter. The pH Was adjusted to 5 .6—6.0, With

media Was inositol, 100 mg; xylose, 250 mg; and MES
buffer, 2.0 g. In addition, K3 media also contained 10 ml per

by dissolving the folloWing into one liter H2O: H3BO3, 6.2

rial cells Were added directly to six to eight day-old proto
plast cultures in a ratio of 100:1 bacteria to protoplast cells.
At the end of the incubation period, protoplasts Were Washed
three times in W5 media by centrifugation in a sWing-out

contains 10 ml per liter of the folloWing stock solutions:

NH4NO3 (2.7 g/200 ml). Added directly to one liter of K3

Procedure: Transformation With the activator T-DNA tag
Was performed by co-cultivation With Agrobacterium tume

65

HCl. The medium Was steriliZed by autoclavation. Proto
plasts Were then resuspended in 0.4 M K3 media to produce
a ?nal concentration of 106 protoplasts per ml. One ml of
protoplast suspension Was transferred to a standard (100
mm) petri dish and cultured in a ?nal volume of 10 ml of 0.4

M K3 media containing antibiotic selection against Agro

US 6,989,236 B1
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bacterium cells (cefotaxime 500 pig/ml) as well as the

tic (12 cm in length><1-cm dia.) with the maceration end
machined to a semi-circle (one-half of the 1-cm circular end)

presence of hormones to maintain cells in a dedifferentiated

state (auxin (NAA) 1.0 pig/ml and cytokinin (kinetin 0.2

is used to partially macerate the tissue in the well of the
plate. Partial maceration is conducted to break open a

pig/ml). Hygromycin (15 pig/ml) was also added to the

suf?cient proportion of the cells within the 50 mg piece of

incubation media to select for the protoplasts transformed
with the activation-tagging vector.

callus tissue to release the cellular contents for analysis and
to maintain an amount of this tissue (generally about 1/3 of

Example 3

each callus section) in the well to enable continued growth

and recovery. Because the 3H-epibatidine displacement

Propagation of Protoplasts and Calli

10

Culturing of Protoplasts: Transformed cells were embed
ded in 0.3% low gelling temperature agarose in 100 mm
petri dishes. K4 media was then added to the petri dishes

containing the soft agarose embedded microcalli. Following

15

protoplast embedding, the K4 media was reduced in osmo

assay (below) can be used with K4 callus growth media,
recovery and growth of the microcalli within the wells is
virtually 100%. Additional media is added to each well to
increase the volume to 1.0 ml. 0.65 ml of the 1.0 ml volume
of cellular ?uid resulting from the partial callus maceration
in each well is removed and transferred to standard 1.5 ml
micro-centrifuge tubes. After sealing the lids of the 48-well

larity in 0.1 M increments, (starting at 0.4 M sucrose, ~580

dishes with surgical tape (3 M), they are placed in a lighted

mOsm) on a weekly basis by changing the liquid phase

26° C. incubator for recovery and growth. The growing calli
within the 48-well dishes establishes the working library.

media over the soft agarose embedded cells. “K4” media

contains 10 ml per liter of the following stock solutions:

20

Example 5

NaHZPO4 (3 g/200 ml); CaCl2 (18 g/200 ml); KCl (58.8
g/200 ml); glutamine (17.54 g/200 ml); asparagine (5.32
g/200 ml); arginine (3.52 g/200 ml); (NH 4)2SO 4 (2.7 g/200

Extract Preparation

ml); MgSO4 (5 g/200 ml). Added directly to one liter of K4
media is inositol, 100 mg; xylose, 250 mg, and MES buffer,

25

Micro-centrifuge tubes containing 0.65 ml of cell tissue

2.0 g. In addition, K4 media also contains 10 ml per liter of

?uid and K4 growth media are centrifuged at 13,000 rpm for

a micronutrients solution and 1.0 ml per liter of a vitamin
solution with the same composition as that used for the K3
media as well as 5.0 ml per liter of a Fe-EDTA solution and

ten minutes at room temperature. The supernatant is

sucrose to 0.4 or 0.1 M.

removed and placed into clean micro-centrifuge tubes and
stored at —80° C. until used for displacement assays.
30

Example 6

Transfer to Larger Areas for Additional Growth: Once

microcalli were established (usually four to ?ve weeks),
they were released from the agarose by gentle maceration
and dilution. Microcalli were further cultured by “surface
plating” the transformed tissue onto 0.1 M K4 media solidi
?ed with 0.8% agar in 150 mm dishes. The released micro
calli were “re-embedded” in low gelling-temperature agar
ose and plated to the surface of solidi?ed K4 media agar
plates. This results in a 2 mm thick monolayer of embedded
microcalli on the plate such that further growth forms an

[3H]-Epibatidine Screening
35

Tissue Preparation: Crude membrane preparations from
brains of male adult Sprague-Dawley rats were prepared
from methods modi?ed after Houghtling R A, Davila-Garcia

upward protrusion of the calli large enough for physical

M I, Kellar K J, Mol Pharmacol 48(2):280—7, 1995, which
reference is incorporated by reference herein in its entirety.
Following sacri?ce by rapid decapitation, the frontal cortex
and hippocampus were rapidly dissected and homogeniZed

sampling. Dilutions were empirically made to adjust the

in ice-cold sucrose buffer (0.32 M sucrose, 1 mM EDTA, 0.1

number of individual microcalli on each dish to densities

mM phenylmethylsulfonyl ?uoride, 0.01% wt/vol sodium
aZide; pH adjusted to 7.4) using a polytron tissue homog

40

sufficient to enable continued growth of the microcalli up to

Example 4

eniZer. The homogenate was centrifuged at 1000><g at 4° C.
for 10 min. The pellet was resuspended in sucrose buffer and
the centrifugation repeated. The supernatant fractions were

Nondestructive Sampling and Library

centrifugation 15000><g at 4° C. for 20 min. The pellet was

the stage of sampling.

45

combined and the P2 membranes recovered as a pellet after

Establishment

50

centrifuged at 15000><g at 4° C. for 20 min. The ?nal pellet

The three steps of sampling, establishment of a viable

working library and extract preparation of surface-grown

was resuspended in phosphate buffer. Protein was deter

mined by the BCA Protein AssayTM kit from Pierce, Rock

macrocalli are combined into a single process to maximiZe

throughput. Surface-embedded microcalli grown to siZes
ranging from approximately 0.5 cm to 1.5 cm (“macrocalli”)
are deemed sufficient for sampling and establishing the
master library. Under sterile conditions, petri dishes con
taining the surface-grown macrocalli are opened and mac

55

rocalli are individually sampled using ring forceps (4.8 mm
inner ring diameter, Fine Science Tools, Inc. Foster City,

60

results were con?rmed in male Sprague-Dawley rat cere

brum homogenates derived from animals sacri?ced by rapid
decapitation. The preparation of these membranes was iden
tical to bovine homogenates. Frontal cortex was blocked,

then placed in ice-cold HEPES buffer (50 mM) for 10 min.

section is placed into the numbered well of a 48-well

loaded, a maceration pestle, custom made of DelrinTM plas

ford Ill. Aliquots were stored at —80° C. until use.

Preparation of membrane homogenates: Fresh tissue (bo
vine brain) was procured immediately after euthanasia by
exsanguination. Alternatively, standards and replication of

Calif.). This ring siZe enables a section of tissue weighing
approximately 50 mg to be sampled. The removed tissue

microtiter plate containing 0.4 ml fresh K4 media including
required growth regulators. Once the 48-well dishes are

washed twice by resuspension in phosphate buffer (same as
above, except 50 mM phosphate substituted for sucrose) and

65

Tissue was weighed, and 4 ml of “incubation” buffer was
added. Tissue was homogeniZed in a 30 ml vol. glass

hand-held tissue homogeniZer with a te?on pestle. The crude
homogenate was washed 3 times by centrifugation at

US 6,989,236 B1
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35,000><G for 20 min at 4° C. After each centrifugation, the
homogenate was re-suspended in fresh, cold buffer. Follow

Identi?cation of Microcalli with Signi?cant Alkaloid
Displacing Activity: Two stable cell lines were identi?ed

ing ?nal washing, 1 ml aliquots were snap-froZen in liquid

that showed signi?cant alkaloid-displacing activity. One of

nitrogen and stored in a —20° C. freeZer until use. Prior to use

these, 1402, was examined at the whole plant level and
showed a 7.5-fold increase in the level of displacement
activity over the wild type in extracts prepared from leaf

in binding assays, total protein concentration was deter

mined using a modi?ed Lowry method (Sigma Kit) for

punches from nontransformed plants. The second identi?ed
isolate, 5094, showed displacement activity in callus tissue

membrane bound proteins. Protein concentration effects and

protein loss were investigated by preparing aliquots of
known dilutions of membrane protein suspension into wells,
?ltering, and measuring the protein concentration remaining

extracts equivalent to alkaloid levels of several orders of
10

magnitude over the wild-type calli.

on the plate ?lters via the Lowry method.

Example 8

Competition binding: To reduce binding of radiolabel to
?lters, 0.1% BSA was added to the assay buffer. Membranes
were diluted with buffer to yield a ?nal protein concentration

of 600 pig/well (2 mg/ml). Membranes were added to the

Isolation and Replication of Activated Genes
15

Isolation: Molecular genetic techniques are conducted

wells of a 96-well microtiter plate and incubated at room

temperature with 10 nM [3H]-MLA, and unlabelled ligand
or unknown samples (100 pl each). Incubation was halted
after 2 hr by the addition of ice-cold buffer. The contents of
the microtiter plate were harvested onto a 96 well ?lterplate

20

the insert number and structure. Cloning of the T-DNA along
with ?anking genomic plant DNA will depend on the
structure of the insert, ?rst utiliZing plasmid rescue for single

using a plate harvester (Packard, Inc). Filters were washed
5>< with ice cold buffer and the ?lterplate dried overnight.
Scintillation cocktail was then added to the ?lters and the

entire plate counted using a TopCountTM 96-well plate
scintillation counter, Packard Instruments, Meriden Conn.

using standard methodologies. The analytical sequence is
determined by isolating the plant genomic DNA activated by
the T-DNA insert through Southern hybridiZation analysis,
followed by polymerase chain reaction (PCR) to establish

25

site T-DNA insertions. If there are multiple inserts, then
genomic libraries will be prepared and screens conducted on
these to obtain genomic clones linked to the T-DNA that

Procedures for 3H-epibatidine binding in 96-well ?lter

contain different plant genomic DNA sequences. Resulting

plates: All procedures were performed at room temperature,

clones can be sorted ?rst by Southern analysis and then

unless noted. Assays were performed in standard (350 pl
well volume) 96 well microtiter plates. Nicotine or a sample

functionally by reintroduction into wild-type protoplasts and
30

scoring microcalli for the original phenotype. If necessary,

competitor was added to 8 wells at a time using an 8-channel

subclones of the recovered ?anking plant DNA can be

multipipettor. Crude sample extracts were solubiliZed using

prepared and tested for activity by fusing various fragments

1N HCl, if necessary. Unknown samples were diluted with

downstream of the 35S promoter of the Cauli?ower mosaic

incubation buffer (50 mM Tris-HCl, 120 mM NaCl, 5 mM
KCl, 1 mM MgCl2, 2 mM CaCl2, pH adjusted to 7.4) 1:10.
This dilution allows an approximate weight:volume ratio of
100 mg/ml of unknown sample per well. 100 pl of a
competitor was added to each respective well. Non speci?c
binding for epibatidine was determined using 10 mM nico

virus, introducing these back into protoplasts and scoring

tine competition. Membrane homogenates were thawed on
ice and diluted with incubation buffer for ?nal protein

35

these cells for the phenotype. Once the putative activated
genomic DNA is identi?ed, it is used as a probe to screen

cDNA libraries of tobacco. In addition, functional analysis
to determine nicotinic alkaloid pathway upregulation can be

performed by reverse transcription PCR using oligonucle
40

otide primer speci?c to the pmt gene of tobacco. This

provides early molecular evidence if the alkaloid pathway

concentration of each well equal to 4 mg/ml. Membrane

was induced in callus tissue, for example.

homogenate preparation was added to 8 wells at a time,

using 8-channel pipettor. A competitor was incubated within
wells for 1 hr. at room temp. Following incubation of

competitor, 3H-epibatidine (New England Nuclear) was

Example 9
45

We have prepared extracts from about 8000 clonal cul
tures and have screened these for [3H] epibatidine-displacing

added to each well and incubated for 2 hr. Following
incubation, the plate was harvested onto a 96 well GF/B

?lter plate using a Packard 96 well harvester, and rapidly
washed 3x with 350 pl 50 mM Tris-HCl buffer (pH=7.4).
The plate was then allowed to dry overnight, then 30 pl

activity. Approximately 12 of these produced activity that
met the criteria of being “positive” in the ?rst screen. Of
50

MicroScint20TM was added to each well before counting

with a Packard TopcountTM 96-well plate scintillation
counter. Each well was counted for 2 min. Speci?c binding
in the presence of competitor was converted to percentage of

total speci?c binding of 3H-epibatidine alone. Signi?cant

these, only three have met the criteria that daughter cultures
should continue to overproduce activity in the screen

55

through several cycles of growth and separation. The extent
of the increase in activity varies markedly between these
three clones. Thus, the ?rst clone isolated (#1402) producing
a compound or compounds with a biological activity in the
screen equivalent to a concentration of nicotine an order of

differences were calculated from CPM averages using Stu

magnitude higher than that produced by wild-type cultures

dent’s 2 tailed t tests.

(see FIG. 8). A very recent clone (#7309) is producing
activity about 10,000>< that of wild-type whereas the other
clone (#5094) is intermediate between these (FIG. 8).

Example 7

60

Because we isolated #1402 ?rst we have spent most time

Results

characteriZing this clone, and the speci?c ?ndings will be
described below.

Screening of Activation-Tagged Microcalli: 4400 activa
tion tagged microcalli were screened in a six month period.
This was a 75% increase in ef?ciency over previous meth

odologies.

The results show that ATM can be used to create a large
65

library of mutant clonal cultures (see FIG. 4) that can be
maintained by a small number of research workers. We have
also shown that clones in this library can be repeatedly

US 6,989,236 B1
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sampled and separated Without destroying the individual

difference in the screen betWeen clone 1402 and Wild-type

cultures. Extracts from these cultures can therefore be

plants at the mature plant stage illustrates the potential

sampled and screened serially to evaluate Whether the

dif?culties of evaluating differences in natural products in a

genetically produced chemical phenotype is stable. We have
also shoWn that it is possible to adapt pharmacological HTS
techniques to evaluation of a clonal library produced by
ATM, and that the amplitude of changes in secondary

population of mutant intact plants. Metabolic pro?ling of the
plants at this stage by GC/MS also did not reveal any
differences in alkaloid material (see FIG. 7).

metabolites from Wild-type or other control cultures that are

batidine displacement screen it Would seem to be a simple

produced by ATM can be detected by this HTS. We are thus
able to combine ATM and HTS—the ?rst requirement for
proof of the Natural Products Genomics concept. Our results
using this combination of techniques shoW that a small
number of clones (currently around 1 in 2,700 mutants) can
be regarded as stable alterations in genes that increase the

synthesis of products With a biological activity similar to
nicotine. These products may be nicotine itself, or some
other chemical With activity in the screen, at this stage We do
not knoW. Similarly, the genes that have been activated may
have an impact on the nicotine metabolic pathWay, or be
completely unrelated to this. All We knoW is that they

Since 1402 consistently overproduces activity in the epi
matter to establish What compound or compounds it is
10

producing that account for this activity. Unfortunately this is
more dif?cult than Would be expected. The problem is one

of sensitivity and quantitation. The screen is semi-quantita
tive at best, but it is extraordinarily sensitive, being easily
able to respond to picogram quantities of nicotine in a
15

culture extract. Chemical analytical methods such as

GC/MS (as in FIG. 7) are about 1000>< less sensitive, and to
date We have not accumulated enough clonal culture mate

rial to be able to analyZe extracts quantitatively for knoWn
and novel nicotine-like alkaloids. We have therefore used a
20

combination of pharmacological analysis and separation

increase the production of natural compounds With poten
tially useful biological activity that is similar to that of

son With extracts from Wild-type microcallus.

nicotine. In fact, We may Well be underestimating the
numbers of clones that have this type of value. About 75%
of the clones that give a positive result in the ?rst screen

Nicotine is the most pharmacologically alkaloid in the
intact plant, and this alkaloid can be detected by GC/MS in
extracts from Wild-type cultures. Therefore, the most likely

techniques to investigate extracts of clone 1402 in compari

25

eventually fail, sometimes after several generations of posi

reason for the increased activity in extracts from clonal
culture #1402 is that this is producing more nicotine than the
Wild-type cultures. This does not appear to be the case. Thus,
this clonal culture Was identi?ed on the basis of greater

tive daughter cultures. Some cultures even recover activity
after producing negative data for a While. In some cases, this
may indicate that We have activated a gene that regulates the

production of the natural product very indirectly, and that its

30

effects can be over-ridden by other genes that may be

activated by environmental or developmental factors beyond

contrast, nicotine, and the partial agonist cytisine, have a
higher af?nity for nicAChRs on brain containing alpha4

our control. HoWever, such genes might still be useful as a

means of regulating synthesis of the natural product. We
have been deliberately conservative in our criteria to avoid

subunits. If the active principle in clone #1402 is nicotine it
35

the criticisms previously associated With unstable somatic
mutations in plant cell culture. Considered together We

should displace [3H]nicotine or [3H]cytisine from brain
membranes to a greater extent than it displaces [3H]epiba
tidine. In fact the reverse is the case—the same extract from
1402 that is an order of magnitude more effective at dis

believe that our results demonstrate that ATM and HTS have
the potential to act as a discovery platform for those genes

that regulate the synthesis of natural products in plants. As

displacement of epibatidine, a ligand With relative selectiv
ity for alpha3-containing nicAChRs on brain membranes. In

placing epibatidine is no more effective than that from

our characteriZation of clone 1402 has shoWn (see beloW)
this Natural Products Genomics approach has utility as a

Wild-type cultures in displacing nicotine or (see FIG. 9).
This suggests that Whatever is responsible for the activity
has a greater af?nity for alpha3-containing nicAChRs, and

drug discovery platform technology.

this is inconsistent With this being nicotine or probably any

Clone 1402 has noW consistently over-produced activity
in the epibatidine displacement screen for about 18 months.
This has been in various incarnations of the original clonal
material that originated from a single protoplast subjected to

40

45

of the other major alkaloids in tobacco (see beloW).
FIG. 9 also shoWs another important pharmacological
characteristic of the culture extracts. The dilution/response
relation in the screens is very similar to that for pure

ATM (see FIG. 8). Thus, daughter cultures of the original

nicotine. This suggests that the displacement of the respec

clone continued to overproduce activity in the screen. Some
of these cultures Were regenerated into intact plants Which
set seed. Extracts of the seed Were screened, and these
continued to shoW greater activity in the screen than Wild
type N tabacum seed. Plants Were groWn from this seed and

tive radioligands is by direct competition for the binding

leaf punch extracts from young seedlings shoWed greater
activity in the screen than leaf punches from Wild-type
seedlings. Leaf protoplasts from these plants Were groWn to

50

site, rather than by indirect or allosteric effects. This type of
interaction suggests an alkaloid that is a structural relative of

nicotine rather than a totally different type of compound. For

55

example We knoW that the cultures produce polyamines (see
beloW) and these compounds can affect nicAChR binding
allosterically. The suggestion that the compound in clone
1402 is structurally similar to the knoWn tobacco alkaloids

from relatively mature plants. At this stage nicotine produc
tion is rising rapidly in the Wild-type plants and this might

is supported by results from serial fractionation of the
extracts from #1402 and Wild-type cultures. We compared
these fractions for activity in the radioligand binding screens
and also compared the recovery in each phase With that of
standards representing the major alkaloids present in N
tabacum. In general, the activity in extracts from #1402

Well eliminate the difference from the clonal plant. Addi

shoWed a similar distribution to that from Wild-type cultures

the microcallus level and these microcalli Were found to be

still overproducing activity relative to Wild-type cultures.
The only situation in Which clone 1402 Was not found to
be an overproducer relative to Wild-type Was in leaf punches

60

tionally, assessing the production of nicotine-like alkaloids
in leaf punches from mature plants is subject to the Heisen

berg principle because leaf damage massively increases the
synthesis and transport of nicotine. Our failure to observe a

65

and to that of alkaloid standards (not shoWn here).
Taken together, all this data is consistent With the pro
duction, by clone 1402, of an alkaloidal compound (or
compounds) With structural similarity to nicotine, but Which

US 6,989,236 B1
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bind With high af?nity to nicAChs containing alpha3 sub

We claim:

1. A method for identifying plant genetic material Whose

units. Since none of the major alkaloids in the plant have
exactly these characteristics, then We appear to have pro
duced a stable mutation that causes “overproduction” either
of a compound that is not normally found in the plant, or one

actions cause increased production of a metabolite or

metabolites of interest in plant cells, said method compris
5

ing:
a) causing random integration into the plant genome in

that is normally produced in very small amounts. This

plant protoplasts of at least one enhancer-containing
T-DNA genetic element harboring sequences to enable

?nding, and the procedure We used to come to this conclu

sion, has some implications for drug discovery. Speci?cally,

bacterial replication and selection;
b) groWing said protoplasts to the stage of callus cultures;

if the main purpose of this technology is to discover clones

that are producing active compounds other than the major
active principle in the plant, it is a simple matter to use
differential activity in tWo related screens to do this. Those

c) sampling said callus cultures in such a manner as to

clones that are simply overproducing the “Wild-type com
pound” Will produce a characteristic ratio of activity in the

groWth and recovery,
d) analyZing said cells by at least one radioligand dis
placement assay to identify the callus cultures produc

retain viability thereof and to obtain cells for continued

tWo screens. Those that are producing some product With 15

ing the metabolite or metabolites of interest, Wherein
the radioligand is a nicotine acetylcholine receptor
antagonist or a nicotine acetylcholine receptor agonist;
and

novel properties Will usually produce a ratio of activity that
differs from this.
Since the T-DNA that has been inserted into the N

tabacum genome during the ATM procedure is “tagged”

e) isolating and identifying the plant genetic material, the

With bacterial DNA, it is a relatively simple method to
rescue this material together With sections of the plant genes
surrounding it. HoWever, this does not guarantee that the
piece of plant DNA that is obtained is responsible for the
altered chemical phenotype. Thus the in?uence of the viral

action of Which has been stimulated by the enhancer

containing T-DNA genetic element in the sampled,
identi?ed callus cultures.

2. Amethod of claim 1, Wherein the plant genetic material

enhancer sequences inserted into the genome extends for as 25 Which is identi?ed is a plant gene Whose action causes a
plant cell to produce an increased amount of a metabolite or
much as 10-Kb pairs in each direction from the insert, and
metabolites of interest.
it may be any gene Within this range that is of value for

3. Amethod of claim 2, Wherein the plant genetic material

natural product synthesis. Another potential problem is that

Which is identi?ed is a regulatory gene.

there may be more than one insert. The important activation
may be in one of these rather than the other or, possibly, it

4. A method of claim 1, Wherein the analysis of callus
cultures detects the production of metabolites of interest

could require both. Fortunately clone #1402 has only one
T-DNA insert and We have used plasmid rescue techniques

having pharmacological properties.

to obtain genomic plant DNA from the region of this insert.
To date We have isolated approximately 1.8-Kb pairs of this
material (see FIG. 10), Which is probably of insuf?cient
length to encode a complete gene. HoWever, the sequence
analysis indicates very strongly suggests that the cloned
genomic DNA does indeed encode intact genes in that the

5. A method of claim 1, Which comprises the further step
of propagating at least one callus culture producing said
35 metabolite or metabolites.

6. A method of claim 1, Wherein said plant is a tobacco

plant.

deduced amino acid sequence from this region reveals some

homology With expressed genes When compared With exist
ing gene databanks. In particular, there is homology With

40

is delivered to the plant via Agrobacterium tumefaciens.
9. A method of claim 1 Wherein said radioligand is a

expressed sequence tags obtained from a soybean roots that
represents a gene of unknown function (FIG. 10). Since the
nicotine alkaloids are synthesiZed in roots, this at least

shoWs the expected tissue speci?city.

7. A method of claim 1, Wherein said enhancer sequence
is a plant viral enhancer sequence.
8. A method of claim 7, Wherein said enhancer sequence

nicotinic acetylcholine receptor agonist.
10. A method of claim 1, Wherein said radioligand is a
45

nicotinic acetylcholine receptor antagonist.
11. A method of claim 1, Wherein said radioligand is

Those skilled in the art Will recogniZe, or be able to
ascertain using no more than routine experimentation, many

3H-epibatidine.

equivalents to the speci?c embodiments of the invention
speci?cally described herein. Such equivalents are intended
to be encompassed in the scope of the folloWing claims.

3H-methyllycaconitine.

12. A method of claim 1, Wherein said radioligand is
*

*

*

*

*

